Description
The vector of anti-LTβR chimeric antigen receptor (CAR) is constructed for the engineering of T cells to target human LTβR. The T cells are genetically modified through transduction with a lentiviral vector expressing scFv of anti-LTβR antibody linked to CD3ζ signaling domains. And the vector product was designed for the treatment of Breast Cancer